UroGen Pharma Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/01/2024 257.57% HC Wainwright & Co. $60 → $60 Reiterates Buy → Buy 06/14/2024 218.83% Ladenburg Thalman

BenzingaJul 1 06:53 ET

H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $60

H.C. Wainwright analyst Ram Selvaraju maintains $UroGen Pharma Ltd(URGN.US)$ with a buy rating, and maintains the target price at $60.According to TipRanks data, the analyst has a success rate of 36.9

Moomoo NewsJul 1 06:31 ET · Ratings

TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $102

TD Cowen analyst Tara Bancroft maintains $UroGen Pharma Ltd(URGN.US)$ with a buy rating, and sets the target price at $102.According to TipRanks data, the analyst has a success rate of 50.0% and a tot

Moomoo NewsJun 21 06:33 ET · Ratings

Goldman Sachs Maintains UroGen Pharma Ltd(URGN.US) With Hold Rating, Maintains Target Price $22

Goldman Sachs analyst Paul Choi maintains $UroGen Pharma Ltd(URGN.US)$ with a hold rating, and maintains the target price at $22.According to TipRanks data, the analyst has a success rate of 52.1% and

moomoo NewsJun 18 14:32 ET · Ratings

UroGen Pharma Stock Slumps After Pricing Stock and Warrants Offering

Seeking AlphaJun 18 09:00 ET

NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 0.2% on Tuesday.Shares of NextEra Energy, Inc. (NYSE:NEE) fell sharply in today's pre-market trading after the compan

BenzingaJun 18 08:39 ET